Ross was selected to join the Target Product Profile Technical Advisory Group. WHO is targeting a 50% reduction in deaths and disabilities caused by snakebite envenoming (snakebite) by 2030. To achieve this, access to safe, effective, and affordable antivenom in snakebite endemic countries, particularly in Sub-Saharan Africa, is critical. WHO is exploring a pathway for prequalification of antivenoms and identified a need to develop Target Product Profiles (TPPs) to support optimization of current and emerging products. WHO, in close collaboration with DNDi, will work on the development of TPPs for snake antivenom products for Sub-Saharan Africa and other snakebite endemic regions. Resulting TPPs will assist product standardization and guide more targeted research and development of antivenoms across the world
https://www.who.int/news-room/articles-detail/technical-and-scientific-advisory-group-on-the-development-of-target-product-profiles-for-snake-antivenom-products

The evaluation identified outstanding issues that impacted project implementation and completion. It assessed the project’s relevance in relation to the Mid-term review of the National Health Plan and current health sector needs. The efficiency of consultants, resources, and the capacity of the executing and implementing agencies to deliver project outputs was evaluated. Best practices and lessons learned were identified. Based on the findings, recommendations were provided for necessary changes or re-scoping to improve project outcomes and ensure successful completion in alignment with health sector priorities

Evaluation involved collecting data relevant to the evaluation criteria of project relevance, effectiveness, efficiency, sustainability, and impact. Specific objectives included assessing the overall performance and impact of the Response Fund in controlling HIV/STIs in the Pacific and its contributions to regional complementary funds. The evaluation also focused on SPC’s role as the Principal Recipient (PR), responsible for fund administration, management, and delivery. Additionally, the effectiveness of capacity development and technical assistance under PRISP II was assessed, along with the financial sustainability of the project and its contributions to gender equality, human rights, and value for money

Responsible for collecting data relevant to the evaluation criteria of relevance, effectiveness, efficiency, sustainability, and impact. Prepared evaluation report for $100 million loan

The evaluation project consulted a range of stakeholders, including provincial governments, health bureaus, staff using supported facilities, beneficiaries, local leaders, and partners. Field visits were conducted in six provinces with the largest investments, visiting both the largest and smallest supported facilities. Information was collected using a standard data collection instrument, covering civil works, equipment, training, financial management, and monitoring. A financial and economic evaluation of the project was conducted, including an analysis of pre-project and post-project conditions. Issues affecting project implementation, such as delays, were reviewed to determine causes, key factors, and to propose mitigation strategies

A cost analysis of existing services was conducted across high, medium, and low insurance coverage scenarios. It included projections for a new service package delivered as a standalone offering, alongside routine services, or as an integrated package. Key budget estimates covered personnel, drugs, medical supplies, and capital expenditures. Additionally, calculations assessed the adequacy of the capitation fund and various provider payment mechanisms. This analysis provides essential insights for optimizing healthcare service delivery in relation to available resources and coverage levels.

The study assessed the economic impact of the HIV/AIDS epidemic. Key tasks included conducting a poverty analysis and developing a poverty profile that quantified the impact of HIV/AIDS on poverty, including a gender-disaggregated level, focusing on incomes, savings, assets, schooling, family size, and the vulnerability of the poor and near-poor to health-related shocks in selected countries in the Asia and Pacific region. The study was presented at ICAPP in Sri Lanka and featured as a lead health story in the Times of India.

Unitaid manages a portfolio of 40 grants, valued at US$1 billion. During 2017, US$303 million in grants were approved focusing on malaria during pregnancy, emergency child artesunate treatment, HIV self-testing kits in Africa, and TB prevention for high-risk groups. Member of proposal review commitee for 4 years. 

Secondary data was collected to assess the overall achievements of the project, including conducting economic and financial analysis. The evaluation focused on key benefits such as improved health status in the project provinces, evidenced by increased service use in preventive medicine systems, enhanced health surveillance and disease control, upgraded provincial health systems, improved staff capacity, and effective project management. The project's financial sustainability was also assessed. Based on these findings, recommendations were provided for future project operations, and lessons learned were summarized to inform the planning and implementation of similar initiatives

Participation on the Commitees involved providing country grant renewal recommendations to the Board and offering mid-term and long-term programmatic, financial, and policy recommendations for the US$ 7.3 billion 2011-2015 portfolio. It included an independent, systematic review of new proposals and monitoring existing support to countries. Budget impact analysis was conducted, along with an assessment of outcomes for various vaccines, including pneumococcal, rotavirus, pentavalent (DTP-hep B-Hib), HPV, polio, measles, rubella, yellow fever, and Meningitis A. 

The project developed a framework to analyze the costs and benefits of the overall AACES program, covering projects in water and sanitation, mother and child health, HIV/AIDS, food security, law and justice, and reproductive health. It involved benchmarking and comparing the costs and benefits of AACES against a range of other activities funded by AusAID in Africa. The analysis aimed to assess the efficiency and effectiveness of the AACES program relative to similar initiatives, providing insights for improving future program design and funding decisions

The study reviewed and compiled existing data on the prevalence of counterfeit HIV, TB, and malaria medicines in the Mekong region and quantified their economic impact. It focused on estimating the financial value of counterfeit drug sales relative to the overall market for these infectious disease medicines, as well as the economic costs to households and national economies from using drugs with low efficacy. A model was developed to assess the economic consequences of counterfeit drug use in Laos, Cambodia, and Vietnam, including increased lost workdays, carer costs, and higher health expenditures

Key tasks included providing orientation for provincial health teams on financial analysis of provincial health systems and evaluating the fiscal situation in eight provinces, including their allocation mechanisms.

Additionally, basic provincial health accounts were prepared for each province, detailing sources and uses of funds. Projected cost analyses were conducted for a new package of services under various scenarios, including delivering the package as the only activity, offering OPB services alongside routine services, and implementing an integrated package.

The cost analysis covered major budget lines such as personnel, drugs and medical supplies, and capital expenditures. It also assessed the adequacy of the capitation fund and explored different provider payment mechanisms.

The general objectives of the Joint Assessment included assisting the government in finalizing a detailed medium-term national Avian Influenza operational program. The assessment evaluated the national operational program regarding its breadth, prioritization, and sequencing of activities. A comprehensive financing plan for implementing the Work Program was developed, incorporating support from all Official Development Assistance (ODA) sources and identifying potential financing gaps. Key tasks for the consultant involved costing plan components using Costab  tables, preparing the financing plan, and establishing contract packaging. The results of the evaluation were summarized in a Joint Evaluation Report, which was endorsed by the international donor community and served as a reference for activities supported by donor agencies

Panel assesses the strategic focus, technical soundness, and potential for impact of funding requests in accordance with the Global Fund strategy

Tasks involved conducting discussions with key stakeholders, including the ADB resident mission, government agencies, and development partners. Relevant national health sector policies were identified and analyzed. A draft health country strategy report was produced, incorporating recommendations from stakeholders. Additionally, a dissemination workshop was organized to share findings and engage stakeholders in discussions on the report’s content and recommendations. The process facilitated collaboration and ensured that the insights and feedback from all relevant parties were considered in the final report and subsequent project decisions

The evaluation determined the impact and outcomes of the HIV program in Georgia, assessing the quality of services where data was available. Unit costs for prevention, treatment, care, support, and program management activities were estimated. The evaluation identified the most effective interventions being implemented to address the epidemic and achieve future impact. Additionally, it outlined expenditure implications for the next three years, considering potential re-programming scenarios. The findings provided insights about the program’s effectiveness, cost efficiency, and strategic direction for continued HIV response in Georgia

The project involved the preparation of an Independent Completion Report (ICR), which included directing team inputs and responsibilities, coordinating in-country mission logistics, and ensuring the delivery of high-quality reports. Ross managed the ICR team, effectively utilizing each team member's expertise to meet the Terms of Reference and contractual obligations. He took primary responsibility for evaluating key areas such as overall program design, program management, monitoring and evaluation (M&E), gender considerations, and other relevant aspects. The ICR aimed to assess the project’s performance, outcomes, and alignment with its intended objectives and impact

Cost-benefit models were developed, and a report was prepared to document the economic evaluation of projects within the research center’s portfolio. This evaluation focused on four key elements: developing more cost-effective tools and systems for disease detection and surveillance; transferring knowledge and technologies to public health, environmental, and community sectors by enhancing national and international collaborative linkages and networks within Australia and the Asia-Pacific region; and equipping researchers, professionals, and community members with the necessary knowledge and skills to respond effectively to emerging infectious disease threats. The report provided insights into the economic implications of these initiatives

Key tasks included conducting resource needs estimations based on the costing of a minimum package of effective interventions for HIV prevention aimed at adolescents and young people. A differential analysis estimated the required resources for interventions targeting "most-at-risk" adolescents (MARAs), especially vulnerable adolescents (EVAs), and the general population perceived as “low or no” risk of HIV. Specific packages were costed, including peer education and outreach, youth-friendly services (STI diagnosis, treatment, HIV testing, and counseling), drug-related harm reduction services, life skills-based education in schools, community outreach, information, education and communication (IEC) campaigns, mass media campaigns, and policy interventions.